Table 3.

Description of studies, sites, sampling and quality assessment (n = 12)

No.	Author, year	Country	Sample population	Study design	Bias assessment criteria
1	Fantini et al., 2023	Italy	N = 144	Randomized control trial	11/13
2	King et al., 2019	USA	N = 51 n(f) = 60.8%	Randomized control trial	9/13
3	Lyden et al., 2022	USA	N = 891, randomly assigned to assessment-only control group; n = 300, n = 531 is randomly assigned to the intervention group	Randomized control trial	11/13
4	Morris et al., 2022	USA	N = 73	Randomized control trial	7/13
5	Norman et al., 2017	UK	N = 2,951 s (experimental group) =2,682 post-intervention measures s1(m) = 1,214, s2(f) = 1,444	Randomized control trial	11/13
6	Norman et al., 2019	UK	N = 407	Randomized Control trial	11/13
7	Patrick et al., 2021	USA	N = 891 N (assessment-only) = 300 Stage 1 intervention = 295 Late stage 1 intervention = 296	Randomized control trial	11/13
8	Pueyo‐Garrigues et al., 2023	Spain	N = 50, intervention group; n = 23, comparison group; n = 27	Randomized control trial	11/13
9	Sebire et al., 2019	USA	N = 149	Randomized control trial	11/13
10	Tahaney and Palfai, 2017	US & Canada	N = 113	Randomized control trial	8/13
11	Wisk et al., 2021	USA	N = 122	Randomized control trial	11/13
12	Yurasek et al., 2017	USA	N = 530; 96% Caucasian, 67% male BMI; Marijuana users n = 118	Randomized control trial	11/13